9 May 2012:OrganOx
OrganOx Completes Series C Funding
24 April 2012:Summit plc
Summit Receives Regulatory Approval to Enter SMT C1100 into a Phase One Clinical Trial
18 April 2012:Summit plc
Company update: Future Board Changes
March 2012:Zyoxel
ZYOXEL ANNOUNCES EXCLUSIVE AGREEMENT TO COMMERCIALIZE LIVERCHIP TECHNOLOGY
March 2012:Oxtex
LBA syndicate helps to close Oxtex in 150,000 pound funding round
February 2012:OrganOx
Transplant breakthrough as livers 'kept alive' outside body giving hope to hundreds
February 2012:Oxford Nanopore Technologies Ltd
January 2012:Oxford Cancer Biomarkers
Quintiles Forms New Biomarker Research and Development Company
September 2011:Oxtex Ltd
Oxtex wins Best Emerging Medtech Award
September 2011:Oxtexs Ltd
Oxtexs Limited Appoints Dr Nicholas Edwards
August 2011:Eykona Technologies Ltd
3D Wound Measurement Business Closes Funding Round
July 2011:Oxford Yasa Motors Ltd
YASA Motors Achieves IS09001:2008 Certification
19/07/2011:Oxford Photovoltaics Ltd
MTI leads 650,000 pound funding round in Oxford Photovoltaics Ltd
27/06/2011:Immunotec
01/06/2011:Immunotec
Tuberculosis Expert Joins Oxford Immunotec as Senior Scientific Advisor
26/05/2011:Adaptimmune
Adaptimmune announces Opening of Phase I/II Clinical Trial in Multiple Myeloma
15/04/2011: Oxford Catalysts Group PLC
GTL Demonstration Plant Update
29/03/2011: Avacta
16/03/2011: Oxford Nanopore Technologies
Accelrys and Oxford Nanopore Enter Software Partnership for DNA Sequencing Data Analysis
15/03/2011: InhibOx
InhibOx and COSMIC Discoveries Align to Deliver Full Service Drug Discovery Offering:
14/03/2011: Summit Corporation plc
SMT C1100 increases utrophin in DMD patient muscle cells to therapeutically beneficial levels:
You can also browse older news items in the news archive.
To view details and presentations of past events and information of future events please visit our events page.
back to top